Erratum: Carnosol, a Constituent of Zyflamend, Inhibits Aryl Hydrocarbon Receptor-Mediated Activation of CYP1A1 and CYP1B1 Transcription and Mutagenesis (Cancer Prev Res (2012) 5 (593–602) DOI: 10.1158/1940-6207.CAPR-12-0002)

This article (1) has been retracted at the request of the authors. There was evidence of data falsification or fabrication found in two panels of Fig. 4. Suspicious duplications of band images were found in Fig. 4A and Fig. 4B, and evidence is consistent with these bands being three sets of duplicates. A copy of this Retraction Notice was sent to the last known e-mail addresses for the 7 authors. Three authors (Z.-L. Zhao, K. Subbaramaiah, and A.J. Dannenberg) agreed to the retraction; 4 authors (A. Mohebati, J.B. Guttenplan, A. Kochhar, and W. Kosinska) did not respond. The authors apologize to the scientific community and deeply regret any inconveniences or challenges resulting from the publication and subsequent retraction of this article.